These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10434285

  • 1. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
    Kleinebudde P, Schröder M, Schultz P, Müller BW, Waaler T, Nymo L.
    Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
    [Abstract] [Full Text] [Related]

  • 2. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 3. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S, Newton JM, Bloor JR, Hayes G.
    Int J Pharm; 2002 May 15; 238(1-2):61-76. PubMed ID: 11996811
    [Abstract] [Full Text] [Related]

  • 4. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov 15; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 5. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM, Augsburger LL, Pope DG, Shah RD.
    Pharm Dev Technol; 1996 Dec 15; 1(4):325-31. PubMed ID: 9552316
    [Abstract] [Full Text] [Related]

  • 6. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.
    Basit AW, Newton JM, Lacey LF.
    Pharm Dev Technol; 1999 Dec 15; 4(4):499-505. PubMed ID: 10578503
    [Abstract] [Full Text] [Related]

  • 7. The behavior of different carrageenans in pelletization by extrusion/spheronization.
    Thommes M, Kleinebudde P.
    Pharm Dev Technol; 2008 Dec 15; 13(1):27-35. PubMed ID: 18300097
    [Abstract] [Full Text] [Related]

  • 8. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM, Heng PW.
    Chem Pharm Bull (Tokyo); 2001 Nov 15; 49(11):1383-7. PubMed ID: 11724226
    [Abstract] [Full Text] [Related]

  • 9. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.
    Loka NC, Saripella KK, Pinto CA, Neau SH.
    Drug Dev Ind Pharm; 2018 Apr 15; 44(4):632-642. PubMed ID: 29183166
    [Abstract] [Full Text] [Related]

  • 10. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
    Balaxi M, Nikolakakis I, Kachrimanis K, Malamataris S.
    J Pharm Sci; 2009 Feb 15; 98(2):676-89. PubMed ID: 18548618
    [Abstract] [Full Text] [Related]

  • 11. Influence of the surface tension of wet massing liquid on the functionality of microcrystalline cellulose as pelletization aid.
    Elsergany RN, Lenhart V, Kleinebudde P.
    Eur J Pharm Biopharm; 2020 Aug 15; 153():285-296. PubMed ID: 32599270
    [Abstract] [Full Text] [Related]

  • 12. Influence of the degree of polymerization on the behavior of cellulose during homogenization and extrusion/spheronization.
    Kleinebudde P, Jumaa M, El Saleh F.
    AAPS PharmSci; 2000 Aug 15; 2(3):E21. PubMed ID: 11741237
    [Abstract] [Full Text] [Related]

  • 13. Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC.
    Valle BL, Omwancha WS, Neau SH, Wigent RJ.
    Drug Dev Ind Pharm; 2016 Nov 15; 42(11):1903-16. PubMed ID: 27100683
    [Abstract] [Full Text] [Related]

  • 14. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J, Podczeck F, Newton JM.
    Eur J Pharm Sci; 2005 Jan 15; 24(1):35-48. PubMed ID: 15626576
    [Abstract] [Full Text] [Related]

  • 15. Tabletting behaviour of pellets of a series of porosities--a comparisonbetween pellets of two different compositions.
    Nicklasson F, Johansson B, Alderborn G.
    Eur J Pharm Sci; 1999 Apr 15; 8(1):11-7. PubMed ID: 10072474
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
    Rojas J, Kumar V.
    Pharmazie; 2012 Jul 15; 67(7):595-7. PubMed ID: 22888514
    [Abstract] [Full Text] [Related]

  • 17. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A, Souto C, Martínez-Pacheco R.
    Pharm Dev Technol; 2010 Dec 15; 15(6):626-35. PubMed ID: 20148708
    [Abstract] [Full Text] [Related]

  • 18. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR, Koleng JJ, McGinity JW.
    Int J Pharm; 2002 Aug 21; 242(1-2):87-92. PubMed ID: 12176229
    [Abstract] [Full Text] [Related]

  • 19. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R.
    Drug Dev Ind Pharm; 2002 Apr 21; 28(4):451-6. PubMed ID: 12056538
    [Abstract] [Full Text] [Related]

  • 20. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2006 May 21; 63(1):59-67. PubMed ID: 16326085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.